By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Cookies Policy for more information.
DenyAccept

Leifbridge Podcast

Biotech and AI

00:00
00:00
17:39
https://shardcapital.com/wp-content/uploads/2023/11/Biotech.mp3
Truemuzic
New York Vibe

In this week’s Podcast, Ernst Knacke, our Head of Research, and Benny Osei, Investment Associate, discuss the broad topic of biotechnology and AI.

Together, they discuss the biggest developments in healthcare over the next decade by delving into the overlap between AI, diagnostics, drug discovery and treatment. They also discuss the big opportunities they foresee in biotech, as well as what they think are novel ideas, and whether others are just trends.

https://shardcapital.com/wp-content/uploads/2023/11/Biotech.mp3
Truemuzic
New York Vibe

LeifBridge Investment Services, 51 Lime Street, London, EC3M 7DQ

Cookie Notice
Privacy Notice
Business Terms & Conditions
Preference Centre
Complaints

© Leifbridge. All Rights Reserved.

LeifBridge, is a trading name of Shard Capital Partners LLP, which is authorised and regulated by the Financial Conduct Authority (Reference Number: 538762).
Shard Capital Partners LLP is registered in England and Wales (Registered Partnership Number: OC360394).
‍
Registered office: 36-38 Cornhill, London, EC3V 3NG.Some products and/or services mentioned on this website may not be suitable for you and may not be available in all jurisdictions.
‍
No information set out on this website constitutes advice, an advertisement, an invitation, a confirmation, an offer or a solicitation, to buy or sell any security or other financial, credit or lending product or to engage in any investment activity, or an offer of any financial service.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us, based on your particular objectives. If you are still unsure if investing is right for you, please seek independent advice. Shard Capital assume no liability for any loss sustained from trading in accordance with a recommendation.

Site by Yolkk